A5083172675- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Urinary Bladder and Prostate Research
- Radiomics and Machine Learning in Medical Imaging
- Urologic and reproductive health conditions
- Bladder and Urothelial Cancer Treatments
- MRI in cancer diagnosis
- Pelvic floor disorders treatments
- Advanced Radiotherapy Techniques
- Urinary Tract Infections Management
- Urological Disorders and Treatments
- Health Systems, Economic Evaluations, Quality of Life
- Colorectal Cancer Screening and Detection
- Genital Health and Disease
- Ultrasound and Hyperthermia Applications
- Renal cell carcinoma treatment
- Cardiac, Anesthesia and Surgical Outcomes
- Hormonal and reproductive studies
- Medical Image Segmentation Techniques
- Medical Imaging and Analysis
- Sexual function and dysfunction studies
- Photodynamic Therapy Research Studies
- Clinical practice guidelines implementation
- Advanced X-ray and CT Imaging
- Cancer, Lipids, and Metabolism
University College London
2016-2025
University College Hospital
2014-2025
NIHR Surgical Reconstruction and Microbiology Research Centre
2018-2025
London Centre for Nanotechnology
2018-2025
University College London Hospitals NHS Foundation Trust
2015-2024
UCL Biomedical Research Centre
2010-2024
Wellcome / EPSRC Centre for Interventional and Surgical Sciences
2019-2024
Faculty (United Kingdom)
2015-2023
Urological Society of Australia and New Zealand
2020-2023
Royal London Hospital
2002-2023
Men with high serum prostate specific antigen usually undergo transrectal ultrasound-guided biopsy (TRUS-biopsy). TRUS-biopsy can cause side-effects including bleeding, pain, and infection. Multi-parametric magnetic resonance imaging (MP-MRI) used as a triage test might allow men to avoid unnecessary improve diagnostic accuracy.
Multiparametric magnetic resonance imaging (MRI), with or without targeted biopsy, is an alternative to standard transrectal ultrasonography-guided biopsy for prostate-cancer detection in men a raised prostate-specific antigen level who have not undergone biopsy. However, comparative evidence limited.In multicenter, randomized, noninferiority trial, we assigned clinical suspicion of prostate cancer had previously undergo MRI, Men the MRI-targeted group underwent (without cores) if MRI was...
One of the fundamental challenges in supervised learning for multimodal image registration is lack ground-truth voxel-level spatial correspondence. This work describes a method to infer transformation from higher-level correspondence information contained anatomical labels. We argue that such labels are more reliable and practical obtain reference sets pairs than Typical interest may include solid organs, vessels, ducts, structure boundaries other subject-specific ad hoc landmarks. The...
Clinically significant nonmetastatic prostate cancer (PCa) is currently treated using whole-gland therapy. This approach effective but can have urinary, sexual, and rectal side effects. To report on 5-yr PCa control following focal high-intensity focused ultrasound (HIFU) therapy to treat individual areas of within the prostate. was a prospective study 625 consecutive patients with clinically undergoing HIFU (Sonablate) in secondary care centres between January 1, 2006 December 31, 2015. A...
No AccessJournal of UrologyAdult Urology1 Aug 2011Characterizing Clinically Significant Prostate Cancer Using Template Mapping Biopsy Hashim Uddin Ahmed, Yipeng Hu, Tim Carter, Nimalan Arumainayagam, Emilie Lecornet, Alex Freeman, David Hawkes, Dean C. Barratt, and Mark Emberton AhmedHashim Ahmed Division Surgery Interventional Science, University College London, United Kingdom , HuYipeng Hu Centre for Medical Image Computing, CarterTim Carter ArumainayagamNimalan Arumainayagam...
Focal therapy as a treatment option for localized prostate cancer (PCa) is an increasingly popular and rapidly evolving field.